{
  "variant_id": {
    "Gene": "EPOR",
    "Protein_Change": {
      "ref": "W",
      "alt": "R",
      "position": "858"
    },
    "variant_string_id": "EPOR W858R"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "We identified 10 nonsynonymous EPOR variants... These variants were tested using a luciferase reporter assay, which measures the ability of the mutated proteins to activate JAK2 signaling.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "Luciferase reporter assays have been widely used to assess the functional impact of mutations in various genes, including EPOR.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "We performed at least three independent experiments for each variant... Our results show that wild-type EPOR significantly activated JAK2 signaling compared to the empty vector control.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "Our analysis revealed a significant correlation between the mutant EPOR variants and their corresponding OddsPath values... The highest OddsPath score was obtained for the EPO mutation, which corresponds to a >18.7 probability of being pathogenic.",
      "judgment": "Yes"
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The EPO mutation has a very high OddsPath value (>18.7), indicating that it is likely pathogenic and supports the assignment of PS3_very_strong evidence strength."
}